GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Aptus Pharma Ltd
Aptus Pharma Assigned CARE BB; Stable Issuer Rating
RATING ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 27 Jun 2026, 01:40 PM IST  ·  BSE ID: 84d8048e-6654-4421-b472-ac9f2c64d650
View Original BSE Filing (PDF)
💡
In Simple Terms
Credit rating agency CARE Ratings has assigned Aptus Pharma an issuer rating of 'CARE BB; Stable', indicating its general creditworthiness.
🤖 AI Summary
  • Aptus Pharma Limited assigned CARE BB; Stable issuer rating by CARE Ratings.
  • Rating is for the company's general creditworthiness, not specific debt instruments.
  • Rating assigned on June 26, 2026, valid for one year from June 24, 2026.
  • This marks the company's initial public disclosure of a credit rating.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Issuer rating
CARE BB; Stable
🏢 How This Affects the Company
💰
Financial Impact
A credit rating can influence the company's ability to access debt financing and the terms on which it is available.
⚠️
Risk Impact
The 'Stable' outlook suggests no immediate change in the rating, but credit ratings are subject to review and potential revision.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Shareholders should monitor future rating actions and the company's performance.
👤
Who Is Affected
All shareholders are affected as a credit rating can influence the company's borrowing capacity and cost of capital.
🔍
Management Signal
Management's proactive engagement with credit rating agencies indicates a focus on financial transparency and establishing a credit profile.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Company's subsequent financial results disclosures.
Future press release from CARE Ratings detailing the rating rationale.
Any updates on the company's debt financing activities.
MEDIUM RISK Credit rating indicates a specific level of creditworthiness which can impact financial risk.
💡 Investor Takeaway
Aptus Pharma Limited has been assigned an issuer rating of CARE BB; Stable by CARE Ratings, valid for one year. This is the company's first disclosed credit rating.
⚖️ Strengths & Concerns

✅ Positives

  • Assignment of an issuer rating by a recognized credit agency.
📅 Company Track Record
This filing represents the first instance of Aptus Pharma Limited disclosing a credit rating. No prior rating history is available in public filings.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What credit rating has been assigned to Aptus Pharma Limited?
Aptus Pharma Limited has been assigned an issuer rating of CARE BB; Stable by CARE Ratings.
When was the credit rating assigned and how long is it valid?
The rating was assigned on June 26, 2026, and is valid for one year from June 24, 2026.
What does the CARE BB; Stable rating signify?
CARE BB; Stable is an opinion on the general creditworthiness of the company and is not specific to any debt instrument.
Is this Aptus Pharma's first credit rating disclosure?
Yes, based on available filings, this is the first disclosure of a credit rating for Aptus Pharma Limited.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.